Transgene Biotek Limited (TRANSGENE BIOTEK LTD.) Aktie
TRABI.BO
GeschlossenTRANSGENE BIOTEK LTD.
Market Cap
$235,644,688
Über Transgene Biotek Limited (TRANSGENE BIOTEK LTD.) Aktie
Transgene Biotek Limited, a biotechnology company, provides research and development services for bulk drugs in India. It offers a portfolio of oncology drugs, oral drug delivery, and biogenerics. The company provides TrabiDHA for use in health food, baby food/formula, health supplement, and chicken and animal feed markets; Tacrolimus, a drug that suppresses the immune system and is used to prevent rejection of transplanted organs; and Orlistat (tetrahydrolipstatin), a lipase inhibitor that blocks about one-third of intestinal fat absorption. The company was incorporated in 1990 and is based in Sangareddy, India.
Unternehmensinformationen
502325 Sangareddy, India
Analystenempfehlungen
Diese Übersicht gibt einen schnellen Einblick, wie Analysten das Aktienpotenzial basierend auf ihren neuesten Analysen und Kurszielen bewerten.